G'day doctornoh,
ACL's oncology had no value attributed due to inability to fund it. CR changed that.
The way I see the split is; extra costs/directors, extra dilution.
The risk I see with the demerger is that the Fonda arm gets even more undervalued than it already is, as no money will be coming in for 6 months or so.
The net result is likely to be lower overall value IMO.
Happy to be wrong though.
- Forums
- ASX - By Stock
- TSN
- capital raising
capital raising, page-113
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable